Table 2.
Risk factor1 |
AUC (95% CI) |
Change in AUC from base model2 |
P3 |
Improvement in sensitivity4 |
Improvement in specificity4 |
Overall improvement in classification4 |
|||
---|---|---|---|---|---|---|---|---|---|
NRI (95% CI) | P5 | NRI (95% CI) | P5 | NRI (95% CI) | P5 | ||||
Base model with demographic6 factors only |
0.67 (0.63, 0.72) |
|
|
|
|
|
|
|
|
MC1R all variants7 |
0.73 (0.69, 0.77) |
0.058 |
<0.001 |
0.12 (0.05, 0.19) |
0.001 |
0.14 (0.06, 0.23) |
<0.001 |
0.26 (0.15, 0.37) |
<0.001 |
‘R’ variants only |
0.72 (0.68, 0.75) |
0.041 |
0.001 |
0.04 (−0.03, 0.11) |
0.25 |
0.17 (0.09, 0.25) |
<0.001 |
0.21 (0.10, 0.31) |
<0.001 |
‘r’ variants only |
0.68 (0.64, 0.72) |
0.004 |
0.48 |
0.03 (−0.02, 0.07) |
0.28 |
0.02 (−0.04, 0.08) |
0.52 |
0.05 (−0.03, 0.12) |
0.24 |
Self-reported risk factors |
|
|
|
|
|
|
|
|
|
Nevi (none, few, some, many) |
0.72 (0.68, 0.76) |
0.048 |
0.001 |
0.15 (0.07, 0.23) |
<0.001 |
0.09 (−0.00, 0.18) |
0.06 |
0.24 (0.12, 0.36) |
<0.001 |
Pigmentation score8 |
0.73 (0.69, 0.77) |
0.053 |
<0.001 |
0.09 (0.03, 0.16) |
0.004 |
0.12 (0.04, 0.20) |
0.003 |
0.22 (0.11, 0.32) |
<0.001 |
Sun & sunbed exposure9 |
0.69 (0.65, 0.73) |
0.015 |
0.06 |
0.04 (−0.01, 0.09) |
0.1 |
0.04 (−0.02, 0.10) |
0.2 |
0.08 (0.00, 0.16) |
0.04 |
Family history10 |
0.68 (0.64, 0.72) |
0.006 |
0.4 |
0.01 (−0.02, 0.04) |
0.6 |
0.03 (−0.01, 0.07) |
0.2 |
0.04 (−0.01, 0.09) |
0.2 |
Non-melanoma skin cancer11 |
0.70 (0.66, 0.74) |
0.024 |
0.003 |
−0.03 (−0.06, 0.01) |
0.2 |
0.09 (0.05, 0.13) |
<0.001 |
0.06 (0.01, 0.12) |
0.02 |
Physician-measured risk factors |
|
|
|
|
|
|
|
|
|
Nevi 2+ mm |
0.79 (0.75, 0.82) |
0.111 |
<0.001 |
0.10 (0.03, 0.17) |
0.008 |
0.29 (0.20, 0.38) |
<0.001 |
0.39 (0.28, 0.51) |
<0.001 |
Nevi 2–5 mm |
0.78 (0.75, 0.82) |
0.108 |
<0.001 |
0.10 (0.03, 0.17) |
0.006 |
0.30 (0.21, 0.39) |
<0.001 |
0.40 (0.29, 0.52) |
<0.001 |
Nevi 5+ mm |
0.76 (0.72, 0.79) |
0.082 |
<0.001 |
−0.01 (−0.08, 0.06) |
0.8 |
0.33 (0.25, 0.42) |
<0.001 |
0.32 (0.21, 0.44) |
<0.001 |
Nevi dysplastic |
0.70 (0.66, 0.74) |
0.027 |
0.01 |
−0.04 (−0.10, 0.01) |
0.1 |
0.15 (0.09, 0.21) |
<0.001 |
0.10 (0.02, 0.19) |
0.02 |
Nevi raised |
0.74 (0.70, 0.77) |
0.061 |
<0.001 |
−0.04 (−0.11, 0.03) |
0.2 |
0.29 (0.21, 0.36) |
<0.001 |
0.24 (0.14, 0.35) |
<0.001 |
Pigmentation score12 |
0.72 (0.68, 0.76) |
0.047 |
0.001 |
0.11 (0.04, 0.17) |
0.001 |
0.09 (0.01, 0.17) |
0.03 |
0.20 (0.09, 0.30) |
<0.001 |
Solar lentigines | 0.74 (0.70, 0.78) | 0.063 | <0.001 | 0.09 (0.02, 0.16) | 0.01 | 0.17 (0.08, 0.26) | <0.001 | 0.26 (0.15, 0.37) | <0.001 |
AUC Area under the receiver operating characteristic curve, NRI Net reclassification improvement.
1 Each risk factor was separately added to the ‘base model’ to evaluate its influence on risk prediction.
2 The change in the AUC between the base model and the model with the additional risk factor included.
3 Chi-square p-value for the difference in the AUC when compared to the base model.
4 Based on quartile cut-points. Improvement in sensitivity is calculated from reclassification of cases, improvement in specificity is calculated from reclassification of controls, and the overall improvement in classification combines the improvements in sensitivity and specificity.
5 The p-value, representing the statistical significance of the NRI, was calculated using the methods of Pencina et al.[29].
6 Demographic factors include age, sex, city of recruitment and European ancestry.
7MC1R is included as separate continuous variables for each of the six ‘R’ variants and one combined ‘r’ variant variable.
8 Self-reported ‘pigmentation score’ is a continuous variable derived from several self-reported variables including: ability to tan, propensity to sunburn, skin colour, eye colour, hair colour and childhood freckling.
9 ‘Sun & sunbed exposure’ includes total childhood sun exposure hours (quartiles), childhood blistering sunburns (none, ≤ 8, > 8), and lifetime number of sunbed sessions (0, 1–10, >10).
10 Confirmed family history of melanoma in a first degree relative (yes/no).
11 A self-reported previous diagnosis of non-melanoma skin cancer.
12 Objectively-measured ‘pigmentation score’ is a continuous variable derived from objectively-measured: hair colour, eye colour and skin reflectance (inner arm b* measure), and self-reported: ability to tan, propensity to sunburn and childhood freckling.